NFKB1 and inflammatory bowel disease: Indeed, IBD lamina propria immune cells exhibit increased NF-kB activity, and blockade of this transcription factor reduces the production of IL-1β, IL-6, and TNF and attenuates disease in mouse models of intestinal inflammation (39).